Congenital acute myeloid leukemia in Down syndrome
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Congenital leukemia is an uncommon myeloproliferative disorder usually diagnosed in the first month of life. Newborns with Down syndrome have an increased susceptibility to acute megakaryoblastic leukemia. We report a case of a newborn with Down syndrome diagnosed with acute myeloid leukemia. The diagnosis was established by clinical and hematological work-up.
##plugins.themes.bootstrap3.article.details##
congenital leukemia, newborn, Down syndrome
2. Prakash KP, Rau ATK, Bhat ST, Rau AR. Congenital Leukemia – A Diagnostic Dilemma. Indian J Med Paediatr Oncol 2008; 29(4):41-43.
3. Roy A, Roberts I, Norton A et al. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. Br J Haematol 2009; 147:3–12.
4. Sande JE, Arceci RJ, Lampkin BC. Congenital and neonatal leukemia. Semin Perinatol 1999;23(4):274-285.
5. Bresters D, Reus ACW, Veerman AJP, et al. Congenital leukaemia: the Dutch experience and review of the literature, Br J Haematol 2002; 117(3):513–524.
6. Isaacs Jr. H. Fetal and neonatal leukemia. J Pediatr Hematol Oncol 2003; 25(5):348–361.
7. Gruber TA, Downing JR. The biology of pediatric acute megakaryoblastic leukemia. Blood 2015; 126(8):943-949.
8. De Rooij JDE, Branstetter C, Ma J, et al. Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia is Characterized by Distinct Genomic Subsets with Varying Outcomes. Nat genet 2017; 49(3):451-456.
9. Schweitzer J, Zimmermann M, Rasche M, et al. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial. Ann Hematol 2015; 94:1327–1336.
10. Warrier RP, Emami A, Ravindranath Y et al. Perinatal Leukemia: The surface antigens, cytochemistry and cytogenetic features. Indian Pediatr 1983; 20:325-333.
11. Henry E, Walker D, Wiedmeier SE, Christensen RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system. Am J Med Genet 2007; 143:42–50.
12. Lange B. The management of neoplastic disorders of haematopoiesis in children with Downs syndrome. Br J Haematol 2000; 110:512–524.
13. Mathur NB, Joshi N, Singh T, Singh M. Congenital acute megakaryocytic leukemia. Indian J Med Paediatr Oncol 2011; 32(3):165-167.
14. Fatima Shirly AG, Darlington D. A rare case of congenital leukemia: acute myeloblastic leukemia in a neonate with Down syndrome. Int J Contemp Pediatr 2016; 3(1):288-290.
15. Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002; 32:148-152
16. Campwell WA, Storlazzi E, Vintizileos AM. Fetal neonatal leukemia. Arch Dis Child 1962; 37:93–98.
17. Gamis AS, Alonzo TA, Gerbing RB, et al. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Childrens Oncology Group Study A2971. Blood 2011; 26:6752–6759.
18. O'Brien M, Taub J, Stine K, et al. Excessive cardiotxocity despite excellent leukemia-free survival for pediatric patients with Down syndrome and acute myeloid leukemia: results from POG (Pediatric Oncology Group) protocol 9421. Blood 2006; 108:168a-169a.
19. Rao A, Hills RK, Stiller C, et al. Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. Br J Haematol 2006; 132:576–583.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.